Kana Enomoto is a global thought leader and accomplished executive with a strong record of achieving public-policy goals, delivering programmatic impact, and inspiring organizational and social change.
As a partner at McKinsey and the director of brain health for the McKinsey Health Institute, Enomoto works with a wide range of clients, including government entities, payers, providers, investors, employers and not-for-profit organizations to better serve people with or at risk for mental and substance use disorders.
Prior to joining McKinsey, Enomoto was acting administrator for the U.S. Substance Abuse and Mental Health Services Administration, where she provided executive direction and national policy leadership. She also served as senior advisor to the U.S. Surgeon General, where she provided strategic guidance on efforts to combat the opioid epidemic.